Conference Information

ADURS2027 Symposium – February 25-27, 2027, San Diego, CA.

Please Note:  All speaker slides/handouts and most symposium documents are available in DIGITAL FORMAT ONLY.

Registration – Anticipated opening date mid November (subject to change).  State Members should log in to register.  State Non-members must contact the Symposium Coordinator to access their form.  Current corporate attendees will be emailed the link to their form.

Agenda – 9-4-26

Faculty (names, credentials, program title, objectives) – 9-4-26

State & Corporate Attendees

Symposium Travel/Lodging Information – Due to previous unauthorized room bookings by non-attendees, the travel & lodging doc is no longer be available online.

NABP CPE Monitor (link) – for e-Profile number to receive CPE credits

Notice:  All dates subject to change without notice.

Corporate Commitment Forms:  Friday, Sept 4, 2026

Corporate Secure Funding Approval Due:  Tuesday, Dec 1, 2026

Resident Scholarship Applications:  Friday, Oct 9. 2026

Call for Posters:  Friday, Nov 13, 2026

Registration Closes:  Friday, Jan 15, 2027

Registration Fee Payments:  Friday, January 22, 2027 (5 weeks prior to conference)

Speaker Slides:  Friday, January 22, 2027

Roundtable Survey: Friday, January 29, 2027

Corporate Attendee Notice:  ADURS allows up to eleven (11) corporations (For 2026 – nine renewable spots and two wildcard spots) to send a maximum of four (4) attendees each to the annual Symposium.  Corporations attending from the past year will be given first right of refusal for the subsequent year.  Registrations from individual industry representatives not employed with one of the approved corporations will not be accepted.

ADURS Symposiums are funded by registration fees only.  ALL requests to sign contracts and/or agreements in any form will be denied in order to adhere to current ACPE standards.  NO EXCEPTIONS.

Companies interested in attending a future symposium should complete a Listserv form:  https://www.surveymonkey.com/r/ADURSCorpInq2026 

 

**ADURS TRAVEL AND LODGING POLICY**

If attending as a state representative (voting or non-voting) with ADURS paying for travel, hotel and registration, you are agreeing to the following:

  • You will attend all programs (lectures) presented at ADURS
  • You will attend the business meeting if you are the voting member

Failure to attend all required aspects of ADURS without appropriate excuses (we are fully aware that there can and will be times where job obligations will cause conflicts – simply let ADURS staff know if this occurs) will result in this being reported to the ADURS Board of Directors for review.  The Board may choose to revoke the sponsorship and invoice you for all costs of your attendance (travel, hotel and registration) at ADURS.

NOTICE:  (Rev. May 2021)

Accounts are reviewed annually starting March 1st.  Non-member/Attendee/Corporate Attendee level access accounts inactive/dormant for two (2) Symposium cycles will be suspended. Authorization from your Corporation (corporate attendees) or your State Pharmacy Director (state attendees) is required to activate/reactivate your account.  Previous attendance DOESN’T grant automatic authorization/access.

  • Access to specific conference information is limited to Symposiums registered for/attended.
  • Non-member State Attendees (people not on the State DUR Listserv) require preauthorization from your state Pharmacy Director / Administrator to attend/register for the current symposium.  Having an active Attendee account and/or previous symposium attendance doesn’t grant automatic access to the current symposium.
  • State Vendors must be directly involved in that state’s Drug Utilization Review (DUR) program to attend.

ALL UNAUTHORIZED REGISTRATIONS WILL BE DELETED WITHOUT NOTICE.

To adhere to U.S. Copyright Laws, copyrighted images will be removed from published slides/handouts.  Website links may/may not be provided.  Referencing of copyrighted images is not an ACPE requirement and is done as a courtesy ONLY.

*Slides with a significant amount of copyrighted text, graphics, images, etc per cited website(s)’ copyright policies WILL NOT be published online.

https://www.justice.gov/archives/jm/criminal-resource-manual-1852-copyright-infringement-penalties-17-usc-506a-and-18-usc-2319 

ACPE Standards for Integrity and Independence, Guideline 2.3 requires the accredited provider not share the names or contact information of learners (anyone receiving CE credit) with any ineligible company or its agents without the explicit consent of the individual learner. This affects learner contact information published in the conference attendees section the program/roster booklet, the opening night welcome, email requests for attendee lists, etc.

Disclaimer: The ADURS committee members, directors, and staff sections and state Medicaid directors/DUR contacts section of the program booklet are association-related. ACPE accreditation rules require ADURS to publish the Name, Credentials, Title, and Affiliation of conference faculty.

ADURS Code of Conduct & Enforcement Policy (link) 8-7-26
CE Activity Planner & Faculty Member Disclosure to Program Learners

ACPE Standards for Integrity and Independence – Guideline 3: Identify, Mitigate, and Disclose Relevant Financial Relationships

All CE activity planners and faculty members must provide disclosure of relevant financial relationships (no minimum amount) with ineligible companies to learners, even if there are none.  Examples of ineligible organizations may include, but are not limited to:

    • Advertising, marketing, or communication firms whose clients are ineligible companies
    • Bio-medical startups that have begun a governmental regulatory approval process
    • Compounding pharmacies that manufacture proprietary compounds
    • Device manufacturers or distributors
    • Diagnostic labs that sell proprietary products
    • Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
    • Manufacturers of health-related wearable products
    • Pharmaceutical companies or distributors
    • Pharmacy benefit managers (PBMs)
    • Reagent manufacturers or seller
    • Owners and employees of ineligible companies

UAN:
Target Audience: Pharmacists licensed in US states, districts, and territories
Activity Type: Knowledge-based
Activity Release Date: 02/25/2027
Activity Expiration Date: 02/25/2030
Faculty/Contributors: 
Declarations: 

Nahid Assadi, RPh
Rachel Cain, PharmD
Cori Cooper, PharmD
Terry Cothran, DPh
Charlene Fairfax, RPh, CDE
Mike Jockheck, RPh
Brendan Joyce, PharmD
Loralyn Joyce, BS
Shellie Keast, PharmD, PhD
Aimee Lewis, PharmD, MBA
Courtney Nichols, PharmD
Michael Ouellette, RPh
Eric Pittman, PharmD
Sarah Servid, PharmD
Pamela Smith, RPh
Mark Tesell, PharmD, BCPS

Antonio Brown
Cori Cooper, PharmD – Roundtable Facilitor
Brian Haggblom, PharmD
Bethany Holderread, PharmD
Maria Lowe, PharmD, BCPS – Pipeline Traditional
Maria Lowe, PharmD, BCPS – Pipeline CGT
Mckenzie McVeigh, PharmD
Dan Mickool, RPh, MS, EdD
Luke Slindee, PharmD
Kevin Whittington
Lisa Whittington, MS, PharmD, BCPS, BCPP